GZMB and graft versus host disease: Ehx et al. (71) found that AZA significantly decreased human T-cell proliferation as well as IFN-γ and TNF-α serum levels, and it reduced the expression of GRANZYME B and PERFORIN 1 by cytotoxic T cells, leading to the prevention of GVHD.